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Abstract
Sinusitis is the infection of sinuses. Sinuses are four hollow cavities in face which 
are connected to nasal pathways to help moisten, warm and filter the air which we 
breathe in. Sinuses get irritated due to bacteria, virus and allergens. It is often associ-
ated with asthma and headache. Pressure in the sinuses is built by over production 
of mucous and leads to sinus headache. Asthma gets severe with the sinusitis as both 
are related to sino-nasal pathway. Treatment includes steroids, nasal decongestants, 
antibiotics and to avoid allergens which not only reduce the symptoms of asthma but 
also sinusitis. Acute sinusitis may turn into chronic sinusitis including narrowing of 
nasal passages, deviated septum and lumps in the nose (polyp). It can be treated with 
surgical procedures. The only way to prevent sinusitis is by precaution and medica-
tion. Post nasal drip may also associate with asthma causing bronchial constriction.
Keywords: sinusitis, sinus headache, sinus asthma, post nasal drip, treatment, 
factors, prevention
1. Introduction
Sinusitis is swelling or an inflammation of the tissue lining of the sinuses. 
Sinuses are hollow cavities anatomically located within the cheekbone, around 
the eyes and behind the nose. Physiologically sinuses are filled with air and 
contain mucous which helps in moisten, warm and filter the inhaled air. 
Pathophysiologically, when the sinuses get blocked by the mucous, viruses and 
bacteria can grow and cause infection in sinuses [1].
1.1 Types of sinusitis
There are basis four types of sinusitis or rhino sinusitis.
1.1.1 Acute sinusitis
Sudden onset with cold-like symptoms (runny and stuffy nose, fever, facial 
pain). It may last for 2–4 weeks.
1.1.2 Sub-acute sinusitis
It is usually the continuation of acute sinusitis which may last up to 12 weeks.
1.1.3 Recurrent acute sinusitis
It happens several times per year. Four or more episodes of acute sinusitis for 
7 days in 1 year of period.
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1.1.4 Chronic sinusitis
Persistent symptoms of sinusitis for 12 weeks or longer [1].
1.2 Etiology, prevalence and epidemiology
Sinusitis is the inflammation of facial sinuses. Different factors may contribute 
in sinusitis. Sinusitis may develop by the combination of environmental and host 
factors. Acute sinusitis is more common in occurrence as compared to chronic 
sinusitis. High prevalence of sinusitis is in the Midwest, south and among women. 
Sinusitis more often affects children younger than 15 years of age and adults 
25–64 years of age. Common cause of sinusitis is viruses and mostly they are self-
limiting. About 90% of the population who get cold also have viral sinusitis. Not 
only patients suffering with cold have sinusitis elements but atopic patients may 
also develop sinusitis. Risk factors causing sinusitis are viruses, bacteria, fungi, 
allergens, irritants (dander, polluted air, smoke, dust mites) [2].
Other risk factors for sinusitis may involve: anatomic defects such as septal 
deviations, polyps, conchae bullosa, other trauma and fractures involving the 
sinuses or the facial area surrounding them. Rhinitis medicamentosa, toxic 
rhinitis, nasal cocaine abuse, barotrauma, foreign bodies. Patients with nasogas-
tric or nasotracheal tubes. Body positioning, intensive care unit (ICU) patients 
due to prolonged supine positioning that compromises muco-ciliary clearance. 
Impaired mucous transport from diseases such as cystic fibrosis, ciliary dyskinesia. 
Immunodeficiency from chemotherapy, HIV, diabetes mellitus, etc. Prolonged 
oxygen use due to drying of mucosal lining [3].
1.3 Histopathology
Histopathology is the examination of pathological condition of tissues. 
Histopathology of respiratory track reveals incidents 1% of viruses, 3% Streptococcus 
pneumoniae, 6% anaerobes, 2% Streptococcus pyogenes, 2% Moraxella, 21% 
Haemophilus influenza 21%, anaerobes and 4% Staphylococcus aureus. In case of 
chronic sinusitis 20% S. aureus, 20%, 4% S. pneumoniae, 3% anaerobes, 16% 
multiple organisms. About 2–7% are fungal incidences in which most common is 
Aspergillus seen in immunocompromised patients [4].
1.4 Pathophysiology of sinusitis
There are four sinuses in the facial area around the nose i.e. frontal sinus, maxil-
lary sinus, sphenoid sinus and ethmoid sinus. Most commonly sinusitis develops by 
the attack of viruses on the upper respiratory track followed by edema and inflam-
mation of nasal lining. This inflammation leads to thick mucus production that 
obstructs the paranasal sinuses due to which immunity is disturbed and bacterial 
infection appear at once. Allergic rhinitis may proceed in to sinusitis due to ostial 
obstruction. Cilia get immobilized due to heavy nasal mucous discharge which 
further block the drainage. That give the opportunity to the bacteria to enter into 
sinuses by coughing or by nose blowing. Bacterial sinusitis develop after the viral 
attack on the upper respiratory track, symptoms of sino nasal disease may get worse 
in 5 days or become persistent in 10 days [5].
1.5 Clinical presentation of symptoms
Major symptoms shown by sinusitis patients are pain or pressure on face, nasal 
obstruction, hyposmia, nasal and post nasal purulence, facial congestion and 
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fullness, fever. Minor symptoms of sino nasal disease include malaise, headache, 
cough, dental pain, headache, halitosis, otalgia, fatigue [6, 7].
1.6 Physical examination and lab findings
Physical examination is performed after the topical decongestant.
• Physical examination include looking for the facial swelling, looking for the 
periorbital edema, post nasal drip, cervical adenopathy and pharyngitis.
• Anterior rhinoscopy shows mucous crusting, obstructive polyps, mucosal 
edema, frank purulence and other anatomical defects.
• Press the forehead and cheeks for deep tenderness.
• Transillumination of the sinuses are also performed.
• Five important predicators of sinusitis include 1. Abnormal sinus transil-
lumination, 2. Maxillary dental pain, 3. Colored nasal discharge, 4. Poor 
response to nasal decongestants and anti-histamines, 5. Mucopurulent seen on 
examination.
Overall examination of the patient is more valid then to observe single param-
eter to confirm the sinusitis [8].
1.7 Evaluation of lab findings
For the acute sinusitis no laboratory tests are recommended in emergency 
departments because for the acute sinusitis diagnosis is clinically. For the diag-
nosis of maxillary, frontal, sphenoid sinusitis plain sinus X-ray is most accurate. 
In contrast plain X-ray is not suitable for the evaluation of ostiomeatal complex 
or anterior ethmoid cells, which are the originating cell for sino nasal diseases. 
Positive lab test on plain films for sinusitis shows air-fluid levels, mucosal thicken-
ing of 6 mm or even more, sinus opacity. The choice of diagnostic test for sinusitis 
is the coronal CT at a thickness of 3–4 mm. Clinical findings of CT are sinus wall 
displacement, air-fluid levels, sinus opacification, 4 mm or more mucosal thick-
ening. For the chronic bacterial and fungal sinusitis choice of diagnostic test is 
culture and biopsy [9].
1.8 Differential diagnosis
Most of the time rhinitis or upper respiratory tract infection are mistakenly 
diagnose as sinusitis. Maxillary toothache can also be mistaken as pain appeared 
in maxillary sinusitis. Besides this vascular headache, tension headache, epidural 
abscesses, brain abscesses, subdural empyema, meningitis and foreign bodies are 
also madly mistaken as sinusitis [10].
1.9 Malignancy of sinusitis
Sinusitis may spread to the soft tissues of eye orbits, face and bones. Due 
to the malignancy periorbital cellulitis, facial cellulitis, blindness and orbital 
abscess may develop. Sinusitis can breach into the brain and cause intra cranial 
disorders such as meningitis, epidural or subdural empyema and cavernous sinus 
thrombosis [11].
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1.10 Treatment strategies
Treatment for sinusitis include, nasal wash, decongestants, humidification, 
nasal sprays, corticosteroids, antibiotics and nasal surgery [12].
1.10.1 Saline nasal wash
Saline nasal wash are in the form of nasal sprays or nasal solutions,  
which are intended to rinse away allergens and irritants and also to reduce  
drainage [13].
1.10.2 Nasal decongestants
Topical as well as systemic nasal decongestants can be used such as pseudo-
ephedrine. Caution should be taken in using decongestants. Oxymetazoline should 
not be used for more than 3 days as it causes rebound congestion. Oral deconges-
tants should be used with special care in hypertensive patients [14].
1.10.3 Nasal corticosteroids
Nasal corticosteroids help in reduction and treatment of inflammation. Nasal 
corticosteroid sprays include beclomethasone, fluticasone, budesonide, mometa-
sone, and triamcinolone. Topical nasal sprays effectively treat mucosal edema but 
they are more effective in chronic sinusitis [15].
1.10.4 Parenteral or oral corticosteroids
These corticosteroids are used in severe inflammation especially if patient is suf-
fering from nasal polyps. Oral corticosteroids have serious side effects when used 
for long term so, it should be used only to treat severe symptoms [16].
1.10.5 Antibiotics
Antibiotics are given in case of bacterial sinusitis. In case of bacterial infection 
amoxicillin or amoxicillin-clavulanate for 10–14 days is the first line treatment. 
Trimethoprim-sulfamethoxazole is effective for some population but there is high 
rate of resistance. If symptoms do not resolve in 7 days then broader spectrum 
agents are used such as augmentin, axetil, cefuroxime, second or third generation 
cephalosporins, fluoroquinolones and clindamycin. For anaerobic bacterial infec-
tion metronidazole can also add in the therapy [17].
1.10.6 Aspirin desensitization treatment
If patient is sensitize to the aspirin and may develop sinusitis then under medical 
supervision gradually larger doses are given to patient to increase the tolerance of 
aspirin.
1.10.7 Immunotherapy
Patients who are sensitive to allergens and these allergens may contribute to 
sinusitis. Immunotherapy is suggested to those individuals. Which help to reduce 
the body reaction against specific allergens.
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1.10.8 Endoscopic sinus surgery
If the medications are not effective in treatment of sinusitis then endoscopic 
sinus surgery would be an option. In this surgery endoscope is used to explore 
sinuses. Depending upon the obstruction source different instruments might be 
used to remove mucous or to scrap polyps [18].
1.11 Use of steroids in atopic patients
Atopy is the development of allergic hypersensitive reactions or IgE-mediated 
reactions. Atopic patients may develop genetic allergic diseases such as asthma, 
rhinitis, and atopic dermatitis. Atopy usually associated with the inhaled or 
food allergens. Topical corticosteroids are the major steroids used for atopy over 
40 years. Among steroids hydrocortisone is the first to be used.
1.11.1 Topical steroids
Acute atopic attack is treated by medium to high strength topical steroid for upto 
2 weeks. These steroids should not be used for face and neck area because of side 
effects. Ointment should be apply within 5 min of twice daily bathing. Patients may 
also suffer from side effects such as atrophy, hypopigmentation, thinning of skin. 
Generally more potent steroids have more side effects.
1.11.2 Systematic steroids
The use of systematic steroid is under controversy for acute atopy. Most of the 
prescribers do not prescribe systematic steroids for acute atopy. For severe cases oral 
prednisone at usual dose of 20 mg/day for 7 days are used. But after discontinuation 
of the medicine, disease relapses quickly [57].
1.12 Prognosis of sinusitis
Patients with acute sinusitis are treated effectively as outpatient with better pre-
diction of disease. Whereas, severe sinusitis of sphenoid and frontal area associated 
with air and fluid accumulation require I/V injection of antibiotics and keep under 
care in hospital. High mortality and morbidity rates are associated with fungal 
sinusitis. Immunocompromised patients should also get hospitalized [19].
1.13 Progression of acute sinusitis into asthma
Acute sinusitis often begins with the symptoms of common cold. These symp-
toms may fade away in less than 4 weeks but if symptoms persist for more than 
12 weeks despite of proper medical treatment then acute sinusitis is converted into 
chronic sinusitis. In chronic sinusitis airways get severely inflamed with either 
bacterial or viral infection, which leads to the development of asthma. Which is 
known as sinusitis related asthma [20, 21].
2. Sinusitis related asthma
Asthma is a chronic disorder that involves airflow obstruction, an underlying 
inflammation and bronchial hyper responsiveness. Asthma is complicated disorder 
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that not only involves larger airways but also small airways. Sino nasal disorders are 
most commonly diagnosed with the asthma. For centuries the continuous existence 
of these pathological conditions has been known. However the link between upper 
airways and lower airways has been not clearly understood. Rhinitis and sinusitis 
are two wide spectrum disorders agonizing the upper airways which are closely 
related to asthma [22].
2.1 Prevalence, risk factors and causes
Allergic rhinitis and sinusitis are one of the risk factor for asthma. Inherited 
differences in asthma prevalence, asthma attacks, constructive and appropriate 
asthma management, thorough education and regular visit to medical health care 
of patients with asthma associated with sinusitis and rhinitis may lead to effectively 
control of asthma and also reduce the risk factor for more prevalence.
Clinical trials on the sino nasal pathological conditions has been conducted 
and it was reported that sinusitis and allergic rhinitis of childhood was severely 
associated with asthma among them 42% of the patients had asthma with sinusitis 
whereas 12.9% of the patients only suffered with asthma. Before the age of 7 years 
if sinusitis is present then it would subsequently lead to asthma. If the sinusitis or 
allergic rhinitis occurred at the age of seven then the chances of developing asthma 
increases three fold. The term “The Allergic March” is used to show the progression 
of the disease from the nose and sinuses to the airways of the lungs [23].
The progression of sino nasal allergic march may proceed before the develop-
ment of sinusitis. In children and infants atopic eczema may leads to sinusitis and 
subsequently to asthma. Comparatively in infants with non-atopic eczema, no 
sinusitis would develop. This confirms that eczema is risk factor for the develop-
ment of sinusitis and asthma as well. Which further strengthen the concept of an 
“Allergic March” that sinusitis, allergic rhinitis and asthma are different diseases but 
still the progressively enhance by allergy [24]. The effect of the first line treatment 
for eczema on the progression and development of sinusitis is still unknown in 
patients with sino nasal disorder. Clinical trials have shown that smoking increased 
three folds the risk of asthma in patients already having sinusitis. Recent publica-
tions have shown that obesity is also one of the risk factor for asthma however 
obesity is not involved in sino nasal disorders as both obesity related asthma and 
sinusitis related asthma follows different pathway and mechanism [25].
These clinical trials and studies verify that the sinusitis and allergic rhinitis are 
contributing factors in asthma progression. If sinusitis can be intervene than the 
development of asthma can be prevented. Another important environmental factor 
that is smoking elevate asthma can be controlled by quitting tobacco [26] (Figure 1).
2.2 Difference between sino nasal disease in asthmatics and non-asthmatics
Sino nasal disease may appear differently in asthmatics then that of general 
population. Literature survey showed that the patients showing nasal symptoms 
and undergo to examine the clinical feature of lower airway disease then it is found 
that most of the patients suffering with the chronic sinusitis and allergic rhinitis 
along with asthma as compared to non-allergic rhinitis. Asthmatic patients associ-
ated with sinusitis progress to nasal polyps and are in much complications of sino 
nasal disease comparing to non-asthmatics. Sinusitis related asthmatics have more 
severe and persistent disease and they need multiple of surgeries as well [27].
Studies revealed that sinusitis may develop asthma progressively but there is 
a difference in between sinusitis related asthma and general population. This is 
strongly supported by data.
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1. In asthmatics upper air way disease appear differently as compared to general 
population.
2. Inflammation in upper and lower air ways in both population would be alike.
3. Increasing severity in the upper air ways going parallel to the severity in lower 
air ways [28, 29].
In asthmatic patients the inflammation in nose and sinuses shows there is disease 
in the lungs. For instance if patient having nasal polyposis inflammation its clinical 
identification feature shows antibody IgE production and eosinophilic inflammation. 
Common inflammatory mediators are release from upper and lower air ways, due to 
which it is difficult to assess pathways that cause Sino nasal inflammation in asthmat-
ics and non-asthmatics [30]. Further clinical studies have performed in which gene 
expression of patient with sinus mucosa polyposis and aspirin sensitive asthma was 
compared with chronic sinusitis and no difference in gene expression was found. 
Further clinical studies on gene assays that is based on testing of lower air way helps 
us to understand how sinusitis is different in asthma patient than non-asthmatics [25].
2.3 Upper and lower air way inflammation
From the literature review it is noted that increase in severity of sino nasal 
disease goes parallel with the lower airways. Recent publication shows that patients 
having severe sinusitis have severe asthma series. This study suggests that sinusitis, 
rhinitis and asthma all are common progression of a single systematic disease [31]. 
Which ids further confirm by more clinical research in which severity in inflam-
mation of lungs is same as in sinuses, nose and systematic inflammation which is 
measured by circulating eosinophilia, hence the severity in sinusitis or sino nasal 
disease is parallel to asthma and also same implies that lymphocyte and eosinophil 
are characteristic feature of upper and lower air way inflammation if upper air way 
go worse than lower air way also get affected in same way [32] (Figure 2).
Figure 1. 
Risk factors for the development of sinusitis and rhinitis which leads toward asthma.
Dysfunction of Olfactory System
8
Sino nasal disorders may increase the risk of lower air way (lungs) diseases 
which can be seen from the clinical studies. It has been shown that children suffer-
ing from allergic asthma and allergic rhinitis due to the dust mites, in that patients 
there was increased exhalation of nitric oxide was found [33]. Studies have also 
shown that in patients with allergic asthma allergens can develop the release of 
eosinophils from bone marrow which shows that sinusitis, rhinitis and asthma 
could be separate diseases but affected by single systematic disease [34].
2.4 Sino nasal disorder associated with asthma
Sino nasal disorders are linked with asthma is supported by the clinical 
research studies i.e. non asthmatic patients with allergic rhinitis have inflam-
mation and abnormalities in lower airway. This is further supported by the fact 
that allergic rhinitis have an increase prevalence for the hyper bronchial activity. 
Another study showed that sinusitis and allergic rhinitis are associated with 
impaired lung functions which are significantly related to duration and exposure 
of sino nasal disorder to the risk factors. These findings suggest that patients 
with sinusitis and allergic rhinitis may have subclinical abnormalities of their 
intra thoracic airways and may be at risk of developing the clinical disease of 
asthma [35, 36] (Figure 3).
2.5 Asthma management
Asthma control appears worse in individuals having sino nasal disorder. Recent 
cross sectional, retrospective and prospective studies between the asthma symp-
toms and sinusitis symptoms have performed. These studies suggested that severity 
in sino nasal disorders increase the severity of asthma symptoms [35].
2.6 Treatment outcomes
Important parameters for the treatment outcome include 1. Early treatment 
of the patient suffering with sino nasal disease to prevent asthma. 2. Treatment 
regimen should be as effective as to treat asthma symptoms along with sinusitis and 
rhinitis [37].
Clinical trials are performed on 147 children treated with specific subcutane-
ous immunotherapy for rhinoconjuctivitis, showed that most of the children do 
not progress to asthma. Recently study was published in which patients treated 
Figure 2. 
Physiological relation between upper and lower air way: Inflammation in upper air way (nose, sinuses) 
develop with parallel to lower air way (lungs) in asthmatic patients.
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with antihistamine and nasal corticosteroids for the treatment of allergic rhinitis 
and airflow obstruction investigated by FEF25–75. It was shown that air flow 
obstruction was treated with in 3 months [38]. Over the decades there has been 
much interest in finding out and establishing treatment for the sino nasal disor-
der which may affect the asthma. However studies were performed among which 
prospective study was disappointing and retrospective study was suggested that 
by treating sinusitis and rhinitis asthma can be prevented from progression [39, 
40]. From the previous trials it was believed that by treating nasal diseases lower 
air way abnormalities can be controlled which can decrease systemic eosinophilic 
inflammation. But in the recent trials it was seen that treatment of rhinitis do 
not affect the lower air way inflammation in any way which was investigated 
by measuring exhaled (nitric oxide) NO [41]. In these double blinded systemic 
controlled trials almost 40 children were subjected to treat with nasal steroids 
along with placebo. The results of the trials suggested that sino nasal inflamma-
tion and systemic inflammation was treated, which were investigated by counting 
eosinophilic cationic protein but unfortunately there was no effect on lower 
air way inflammation (measured by exhaled by NO). These randomized trials 
were contraindicated with the previous trials which were carried on the adults. 
According to previous trials on adults lower air way inflammation was affected 
by measuring exhaled NO which was decreased by treating with nasal steroids. 
These results suggested that the effect of nasal treatment to control asthma or 
lower air way inflammation may vary in different patients sub groups. Not only 
this but also, studies have suggested that surgical treatment of nasal disease may 
also help in managing asthma outbreak. Despite of these clinical trials still there 
is a need to determine how well sino nasal treatment can help in reduction of 
asthma. Investigation of the patients who may have benefit from the treatment of 
nasal disease [41, 42].
Figure 3. 
Progressive gradation of sino nasal disease.
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3. Sinus headache
Headache is a symptom produced by the nervous system in response to distur-
bance or any threat. Hence it is the physiologically protective symptom of nervous 
system. About 90% are the life time incidents of the headache [43]. Headache may 
be primary or secondary as well, depending upon the underlying cause of the pain. 
When no definite pathological cause is identified then the headache is considered as 
primary headache syndrome. The most common primary headache disorders are 
migraine, tension type headache, cluster headache and probable migraine. When the 
cause of headache can be definable under pathological conditions, this type of head-
ache is known as secondary headache. Causes of secondary headache include neo-
plastic, immunologic, metabolic, infectious, traumatic, inflammatory, endocrinologic 
and sinusitis [44]. Patients visited to the otolaryngologist because of their chronic 
headache, it is difficult to diagnose depending on the patients’ presentation whether 
the headache is because of sinusitis or may be the other reason. Endoscopic techniques 
have been well developed for the diagnosis of underlying diseases and their associated 
symptoms. Sinus headaches are headache in which individual may feel pain and pres-
sure around his eyes, cheeks and forehead. Due to differential diagnosis sometimes 
migraine and tension headaches may mistakenly consider as sinus headache [45, 46].
3.1 Prevalence, causes and risk factors
Sinus headaches are mostly associated with other chronic secondary headaches. It 
may cause pain and pressure around facial area and in sinuses and progress the sino 
nasal disorders. Sinus headaches are not related with the sinus infections therefore they 
should not be treated with antibiotics. Sinus headaches may affect any individual but 
they are more prone to those patients who have family history or even previous history 
of migraine or primary headache disorders. It also affects those patients who have 
sinusitis and they also suffered with headaches related with hormonal changes [47].
3.2 Symptoms
Symptoms of sinus headache exclusive of causes may include pressure, pain and 
tension around eyes cheeks and forehead, stuffy filled nose, fatigue, fever, pain may 
worsen upon bending forward or even lie down and pain sensations in upper jaw 
and teeth [48].
3.3 Diagnosis
Headache is pathological disorder of nervous system and it is difficult to diag-
nose the exact cause of headache. After physical examination medical practitioner 
may perform imaging diagnostic test to find out the real cause of headache. Imaging 
tests include:
3.3.1 CT-scan
Cross sectional images of brain, spinal cord and sinuses are obtained by X-ray 
which rotates around the body and displayed on the computer.
3.3.2 Magnetic resonance imaging (MRI)
Cross sectional images of the brain and sinuses are made with magnetic field and 
radio waves.
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These tests are used to diagnose the headache. If sinuses are stuffy filled and 
inflamed than the sinusitis is the definite cause of headache [49].
3.4 Precaution and prevention
Precautions help in reducing the severity and attacks of headache. Healthy life 
style changes may prevent from headache other than using medications.
3.4.1 Exercise
Regular aerobic exercise helps in reduction of tension and prevention of head-
ache. Aerobic exercises include swimming, cycling and walking. Before starting 
intense exercise one should warm up his body because sudden exercise also initiate 
headache. One of the causes of headache is obesity, in that case obese patients need 
to exercise daily in order to reduce headache [50].
3.4.2 Avoid trigger factors
If any odor, taste, food and even caffeine, tobacco triggered headache in the past 
so, one should avoid trigger factors and establish healthy daily routine with regular 
sleep of at least 8 h, try to reduce stress and take healthy diet.
3.4.3 Reduction of estrogen effects
Women who are taking medications such as birth control pills and  
hormonal replacement therapy have episodes of headache and estrogen seems  
to make it worse. Ask your doctor to reduce the dose or to prescribe alternate 
therapy [51].
3.5 Treatment
Most of the time migraine and chronic headaches are assumed as sinusitis 
headache. These type of headaches are treated with prescribed medicine on regular 
basis or to take medicine in order to prevent onset of headache.
3.5.1 OTC analgesics
Chronic headaches can be treated with over the counter pain relievers such as 
acetaminophen, naproxen and ibuprofen.
3.5.2 Triptans
Triptans are most effective in treating migraine headaches. Triptans include 
sumatriptan, almotriptan, frovatriptan, naratriptan and eletriptan. They are avail-
able in form of nasal sprays, tablets and injections. Triptans effect by constricting 
blood vessels and block the pain pathways in the brain.
3.5.3 Ergots
Ergots containing active constituent ergotamine. It is available in combination 
with caffeine. Ergotamine is most effective for the pain which lasts more than 72 h 
but it is less effective than triptans. Migraine related nausea and vomiting may 
get worse because of ergotamine. Overuse of ergotamine also leads to headache. 
Dysfunction of Olfactory System
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Dihydroergotamine is comparatively more effective than ergotamine and have 
fewer side effects [52].
3.5.4 Anti-emetics
Headaches are mostly associated with nausea and vomiting especially in case 
of migraine. Anti-emetic medications such as metoclopramide, chlorpromazine 
and prochlorpromazine are given in combination with other medication to prevent 
nausea and vomiting.
3.5.5 Steroids (glucocorticoids)
Glucocorticoids such as dexamethasone are used in combination with other 
headache medication in order to reduce pain severity. Steroids should be used with 
caution because it causes steroidal toxicity [53, 54].
3.6 Sinusitis or migraine
Sinusitis related headaches and migraine are mostly confused with each 
other in term of diagnosis because signs and symptoms of both ailments are 
overlapped each other. In both type of headaches, condition become worse when 
individual bend forward. However in migraine there are also nasal disorders 
such nasal congestion, stuffy filled nose with watery discharge and facial pres-
sure. Due to these symptoms migraine is mistakenly taken as sinusitis related 
headache by 90% of the patients. Whereas in case of sinus headache there is no 
nausea and vomiting which is usually common in migraine. Duration of sinus 
related headache is from 7 days or even longer however, migraine may last from 
hours to 1 or 2 days [55, 56].
4. Conclusion
Sinusitis is a nasal disorder featured by inflammation of mucosal epithelium of 
sinuses. Clinical studies have published and trials have been conducted which shows 
that the sinusitis and rhinitis are the two crucial disorders associated with asthmat-
ics. Sinusitis and asthma follows the same inflammatory pathways and temporal 
sequence of disease which confirms that their progression is manifested by common 
nasal disorder. Early prevention and treatment of sinusitis is of great interest I order 
to prevent the progression of sinusitis into asthma. Sinus headache is also one of 
the symptoms of the sinusitis. Ninety percent life time incidents of headache are 
reported. Migraine is some time mistakenly taken as sinus headache. Before treating 
headache it should be diagnosed clearly whether the cause of headache is primary 
or secondary. After knowing the sinogenic headache, treatment strategies must 
be followed. Most of the time sinus related headaches are associated with acute or 
chronic sinusitis.
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